The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Stadler, Walter M.
Item TypeName
Concept Cisplatin
Academic Article New chemotherapy regimens for advanced bladder cancer.
Academic Article [New chemotherapy regimens for advanced bladder cancer].
Academic Article Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer.
Academic Article In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
Academic Article Treatment of metastatic urothelial cancer in the post-MVAC era.
Academic Article Gemcitabine doublets in advanced urothelial cancer.
Academic Article Perioperative chemotherapy in locally advanced bladder cancer.
Academic Article Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.
Academic Article A Phase II study of oxaliplatin in urothelial cancer.
Academic Article Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer.
Academic Article A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.
Academic Article Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Academic Article Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
Academic Article A phase II trial of weekly intravenous gemcitabine and cisplatin with continuous infusion fluorouracil in patients with metastatic renal cell carcinoma.
Academic Article Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.
Academic Article Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma.
Academic Article Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
Academic Article Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer.
Academic Article A multicenter, double-blind, placebo-controlled randomized phase II trial of gemcitabine/cisplatin (GC) plus bevacizumab (B) or placebo in patients (pts) with malignant mesothelioma (MM).
Academic Article Phase II trial of adjuvant gemcitabine plus cisplatin (GC) with amifostine cytoprotection in patients (pts) with locally advanced bladder cancer (BC).
Academic Article Predicting Acute Renal Injury in Cancer Patients Receiving Cisplatin Using Urinary Neutrophil Gelatinase-Associated Lipocalin and Cystatin C.
Academic Article Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).
Academic Article Bladder-Preserving Trimodality Therapy With Capecitabine.
Search Criteria
  • Cisplatin